This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Your saved search

Name of saved search:

Search terms:

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1978 May;13(5):384-5, 389.

F Markoe Jr. Hosp Formul. 1978 May.

. 1978 May;13(5):384-5, 389.

No abstract available

Drugs in national health insurance: an effective cost containment mechanism.
Hoff LC. Hoff LC. Hosp Formul. 1978 Jul;13(7):528-9, 532, 534. Hosp Formul. 1978. PMID: 10308291 No abstract available.
NHI drug costs may reach $18 billion.
Small WE. Small WE. Am Pharm. 1980 Jan;NS20(1):17. Am Pharm. 1980. PMID: 7369114 No abstract available.
Hiding the costs of national health insurance.
Meyer JA. Meyer JA. Regulation. 1980 Mar-Apr;4(2):22-8, 58. Regulation. 1980. PMID: 10246482 No abstract available.
Introduction to value-based insurance design.
Kelly AM, Cronin P, Carlos RC. Kelly AM, et al. J Am Coll Radiol. 2008 Nov;5(11):1118-24. doi: 10.1016/j.jacr.2008.06.014. J Am Coll Radiol. 2008. PMID: 18954811 Review.
Implications of pharmacogenomics for drug development and clinical practice.
Ginsburg GS, Konstance RP, Allsbrook JS, Schulman KA. Ginsburg GS, et al. Arch Intern Med. 2005 Nov 14;165(20):2331-6. doi: 10.1001/archinte.165.20.2331. Arch Intern Med. 2005. PMID: 16287761 Review.